Diaceutics PLC (DXRX) — Cash Flow-to-Debt Ratio
Diaceutics PLC (DXRX) has a Cash Flow-to-Debt Ratio of 0.07x as of December 2025, meaning its operating cash flow of GBX696.00K could theoretically repay 0% of its total liabilities (GBX9.53 Million) in one year. See DXRX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Diaceutics PLC Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Diaceutics PLC across 10 annual periods. For the full cash flow conversion analysis, see Diaceutics PLC (DXRX) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Diaceutics PLC (2016–2025)
Year-by-year debt coverage analysis for Diaceutics PLC. Check DXRX operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | GBX1.50 Million | GBX9.53 Million | ▲ +111.3% |
| 2024 | 0.07x | GBX651.00K | GBX8.76 Million | ▼ -68.5% |
| 2023 | 0.24x | GBX1.31 Million | GBX5.56 Million | ▼ -73.4% |
| 2022 | 0.89x | GBX5.10 Million | GBX5.74 Million | ▲ +579.5% |
| 2021 | 0.13x | GBX570.00K | GBX4.36 Million | ▲ +69.4% |
| 2020 | 0.08x | GBX253.00K | GBX3.28 Million | ▲ +127.5% |
| 2019 | -0.28x | GBX-627.05K | GBX2.24 Million | ▼ -52.1% |
| 2018 | -0.18x | GBX-954.04K | GBX5.18 Million | ▼ -143.4% |
| 2017 | 0.42x | GBX1.53 Million | GBX3.61 Million | ▲ +52.9% |
| 2016 | 0.28x | GBX674.01K | GBX2.43 Million | — |